Allegheny Health Network’s Biomarker Moonshot Cancer Research Program Marks Five-Year Milestone, Enrolling More Than 11,000 Patients Across All Cancer Types

Systemwide research initiative uses blood‑based genomics to improve early detection and personalize cancer treatmentPITTSBURGH, June 12, 2026 /PRNewswire/ — Allegheny Health Network (AHN) Cancer Institute today announced that its Biomarker Moonshot Cancer Research Program has surpassed 11,000 enrolled…

Read the full release →

News provided by PR Newswire.